Third Quarter Highlights
(all comparisons made to the
-
Net sales up 50 percent to
$2.9 billion -
Operating income up 61 percent to
$347 million -
Operating EBITDA up 67 percent to
$581 million -
Net income per diluted share up significantly to
$1.42 -
Adjusted net income per diluted share increase of 69 percent to
$1.52 -
RPC Group Plc (“RPC”) integration and synergy realization progressing ahead of plan -
Increased fiscal year 2020 cash flow from operations and free cash flow guidance to
$1.45 billion and$830 million , respectively
Berry’s Chairman and CEO,
“I am happy to report we generated a June quarterly record for net sales of over
“For the
“Our financial profile remains solid as we have a strong liquidity position with over
Consolidated Overview
The net sales growth is primarily attributed to acquisition net sales of
The operating income increase is primarily attributed to acquisition operating income of
The net sales growth in the
The operating income increase is primarily attributed to acquisition operating income of
Engineered Materials
The net sales decrease in the Engineered Materials segment is primarily attributed to an 8 percent base volume decline reflecting the impact of COVID-19 and lower selling prices of
The operating income decrease is primarily attributed to a
Health, Hygiene, & Specialties
The net sales growth in the Health, Hygiene & Specialties segment is primarily attributed to base volume growth of 14 percent, partially offset by lower selling prices of
The operating income increase is primarily attributed to a
Cash Flow and Capital Structure
Our cash flow from operating activities was
Our total debt less cash and cash equivalents at the end of the
RPC Group Plc Acquisition
In
The legacy RPC business saw volumes 7 percent lower primarily attributed to the impact of COVID-19 with weakness in European industrial markets partially offset by growth in grocery, pharmaceutical, and hygiene markets. Excluding the impact of COVID-19 in the quarter, we believe volumes were flat compared to the prior year. We saw improving trends within the segment as the quarter progressed and anticipate sequential improvements over the next several quarters as the COVID-19 headwinds abate. In the near future, we would expect the business to achieve low-single digit growth that would be sustainable over the long-term. In spite of the short-term pressure on volumes related to COVID-19, our team was able to deliver a 35 percent increase in Operating EBITDA primarily driven by cost synergy realizations, favorable product mix, and productivity improvements.
Sale of SFL Business
In
Outlook
While certain markets have been impacted by COVID-19 in a variety of ways, like restrictions on daily activities and changes in consumer demand, we are fortunate to have such a diversified portfolio with strong, stable end markets. As such, we are pleased to report that we are increasing our fiscal year 2020 free cash flow to
We still believe approximately 65 percent of our portfolio is advantaged to neutral with about 35 percent negatively impacted related to COVID-19. Specifically, on volumes, we anticipate our Health, Hygiene & Specialties segment to produce low double-digit growth. Our
We believe the acquisition of RPC is truly a transformational and complementary opportunity for our Company. We intend to realize approximately
Investor Conference Call
The Company will host a conference call today,
About Berry
Non-GAAP Financial Measures and Estimates
This press release includes non-GAAP financial measures such as operating EBITDA, Adjusted EBITDA, Adjusted net income, and free cash flow. A reconciliation of these non-GAAP financial measures to comparable measures determined in accordance with accounting principles generally accepted in
Forward Looking Statements
Statements in this release that are not historical, including statements relating to the expected future performance of the Company, are considered “forward looking” within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “outlook,” “anticipates” or “looking forward,” or similar expressions that relate to our strategy, plans, intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results.
Important factors that could cause actual results to differ materially from our expectations, which we refer to as cautionary statements, are disclosed under “Risk Factors” and elsewhere in our Annual Report on Form 10-K and subsequent filings with the
|
|||||||||||||
Consolidated Statements of Income |
|||||||||||||
(Unaudited) |
|||||||||||||
(in millions of dollars, except per share data amounts) |
|||||||||||||
|
Quarterly Period Ended |
|
Three Quarterly Periods Ended |
||||||||||
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
||||||
Net sales |
$ |
2,910 |
|
|
$ |
1,937 |
|
|
$ |
8,701 |
|
$ |
5,859 |
Costs and expenses: |
|
|
|
|
|
|
|
||||||
Cost of goods sold |
|
2,272 |
|
|
|
1,559 |
|
|
|
6,959 |
|
|
4,737 |
Selling, general and administrative |
|
198 |
|
|
|
125 |
|
|
|
631 |
|
|
392 |
Amortization of intangibles |
|
74 |
|
|
|
38 |
|
|
|
226 |
|
|
119 |
Restructuring and transaction activities |
|
19 |
|
|
|
- |
|
|
|
55 |
|
|
35 |
Operating income |
|
347 |
|
|
|
215 |
|
|
|
830 |
|
|
576 |
|
|
|
|
|
|
|
|
||||||
Other (income) expense, net |
|
(7 |
) |
|
|
136 |
|
|
|
6 |
|
|
159 |
Interest expense, net |
|
110 |
|
|
|
71 |
|
|
|
339 |
|
|
201 |
Income before income taxes |
|
244 |
|
|
|
8 |
|
|
|
485 |
|
|
216 |
Income tax expense (benefit) |
|
53 |
|
|
|
(5 |
) |
|
|
121 |
|
|
41 |
Net income |
$ |
191 |
|
|
$ |
13 |
|
|
$ |
364 |
|
$ |
175 |
|
|
|
|
|
|
|
|
||||||
Net income per share: |
|
|
|
|
|
|
|
||||||
Basic |
$ |
1.44 |
|
|
$ |
0.10 |
|
|
$ |
2.75 |
|
$ |
1.34 |
Diluted |
|
1.42 |
|
|
|
0.10 |
|
|
|
2.71 |
|
|
1.31 |
|
|
|
|
|
|
|
|
||||||
Outstanding weighted-average shares: (in millions) |
|
|
|
|
|
|
|
||||||
Basic |
|
132.5 |
|
|
|
131.5 |
|
|
|
132.4 |
|
|
131.0 |
Diluted |
|
134.2 |
|
|
|
134.2 |
|
|
|
134.3 |
|
|
134.0 |
|
|
|
|
|
|
|
|
|
|||||
Condensed Consolidated Balance Sheets |
|||||
(Unaudited) |
|||||
(in millions of dollars) |
|||||
|
|
|
|
||
|
|
|
|
||
Assets: |
|
|
|
||
Cash and cash equivalents |
$ |
906 |
|
$ |
750 |
Accounts receivable, net |
|
1,471 |
|
|
1,526 |
Inventories |
|
1,318 |
|
|
1,324 |
Other current assets |
|
162 |
|
|
157 |
Property, plant, and equipment, net |
|
4,481 |
|
|
4,714 |
|
|
8,393 |
|
|
7,998 |
Total assets |
$ |
16,731 |
|
$ |
16,469 |
|
|
|
|
||
Liabilities and Stockholders' Equity: |
|
|
|
||
Current liabilities, excluding debt |
$ |
1,925 |
|
$ |
1,935 |
Current and long-term debt |
|
10,760 |
|
|
11,365 |
Other long-term liabilities |
|
2,177 |
|
|
1,551 |
Stockholders’ equity |
|
1,869 |
|
|
1,618 |
Total liabilities and stockholders' equity |
$ |
16,731 |
|
$ |
16,469 |
|
|||||||
Condensed Consolidated Statements of Cash Flows |
|||||||
(Unaudited) |
|||||||
(in millions of dollars) |
|||||||
|
Three Quarterly Periods Ended |
||||||
|
|
|
|
||||
|
|
|
|
||||
Cash flows from operating activities: |
|
|
|
||||
Net cash from operating activities |
|
979 |
|
|
|
571 |
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
||||
Additions to property, plant, and equipment, net |
|
(419 |
) |
|
|
(271 |
) |
Other investing activities |
|
(14 |
) |
|
|
2 |
|
Settlement of net investment hedges |
|
281 |
|
|
|
— |
|
Net cash from investing activities |
|
(152 |
) |
|
|
(269 |
) |
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
||||
Repayments on long-term borrowings |
|
(1,859 |
) |
|
|
(383 |
) |
Proceeds from long-term borrowings |
|
1,202 |
|
|
|
— |
|
Proceeds from issuance of common stock |
|
6 |
|
|
|
43 |
|
Debt financing costs |
|
(16 |
) |
|
|
— |
|
Repurchase of common stock |
|
— |
|
|
|
(74 |
) |
Payment of tax receivable agreement |
|
— |
|
|
|
(16 |
) |
Net cash from financing activities |
|
(667 |
) |
|
|
(430 |
) |
Effect of currency translation on cash |
|
(4 |
) |
|
|
2 |
|
Net change in cash and cash equivalents |
|
156 |
|
|
|
(126 |
) |
Cash and cash equivalents at beginning of period |
|
750 |
|
|
|
381 |
|
Cash and cash equivalents at end of period |
$ |
906 |
|
|
$ |
255 |
|
|
||||||||||||||
Condensed Consolidated Financial Statements |
||||||||||||||
Segment Information |
||||||||||||||
(Unaudited) |
||||||||||||||
(in millions of dollars) |
||||||||||||||
|
Quarterly Period Ended |
|||||||||||||
|
Consumer
|
|
Consumer
|
|
Health,
|
|
Engineered
|
|
Total |
|||||
Net sales |
$ |
1,020 |
|
$ |
718 |
|
$ |
608 |
|
$ |
564 |
|
$ |
2,910 |
|
|
|
|
|
|
|
|
|
|
|||||
Operating income |
$ |
89 |
|
$ |
93 |
|
$ |
84 |
|
$ |
81 |
|
$ |
347 |
Depreciation and amortization |
|
79 |
|
|
62 |
|
|
43 |
|
|
25 |
|
|
209 |
Restructuring and transaction activities (1) |
|
14 |
|
|
2 |
|
|
1 |
|
|
2 |
|
|
19 |
Other non-cash charges (2) |
|
2 |
|
|
2 |
|
|
1 |
|
|
1 |
|
|
6 |
Operating EBITDA |
$ |
184 |
|
$ |
159 |
|
$ |
129 |
|
$ |
109 |
|
$ |
581 |
|
|
|
|
|
|
|
|
|
|
|
Quarterly Period Ended |
|||||||||||||||
|
Consumer
|
|
Consumer
|
|
Health,
|
|
Engineered
|
|
Total |
|||||||
Net sales |
$ |
52 |
|
|
$ |
652 |
|
$ |
603 |
|
|
$ |
630 |
|
$ |
1,937 |
|
|
|
|
|
|
|
|
|
|
|||||||
Operating income |
$ |
(1 |
) |
|
$ |
73 |
|
$ |
60 |
|
|
$ |
83 |
|
$ |
215 |
Depreciation and amortization |
|
4 |
|
|
|
50 |
|
|
46 |
|
|
|
27 |
|
|
127 |
Restructuring and transaction activities (1) |
|
6 |
|
|
|
2 |
|
|
(8 |
) |
|
|
— |
|
|
— |
Other non-cash charges (2) |
|
— |
|
|
|
1 |
|
|
3 |
|
|
|
2 |
|
|
6 |
Operating EBITDA |
$ |
9 |
|
|
$ |
126 |
|
$ |
101 |
|
|
$ |
112 |
|
$ |
348 |
|
|
|
|
|
|
|
|
|
|
(1) |
The current quarter primarily includes transaction activity costs related to the RPC acquisition. The prior year quarter primarily includes restructuring and transaction related costs related to the |
|
(2) |
Other non-cash charges for the |
|
* Prior year has been restated to match our current structure. |
|
||||||||||||||
Condensed Consolidated Financial Statements |
||||||||||||||
Segment Information |
||||||||||||||
(Unaudited) |
||||||||||||||
(in millions of dollars) |
||||||||||||||
|
Three Quarterly Periods Ended |
|||||||||||||
|
Consumer
|
|
Consumer
|
|
Health,
|
|
Engineered
|
|
Total |
|||||
Net sales |
$ |
3,125 |
|
$ |
2,104 |
|
$ |
1,725 |
|
$ |
1,747 |
|
$ |
8,701 |
|
|
|
|
|
|
|
|
|
|
|||||
Operating income |
$ |
195 |
|
$ |
226 |
|
$ |
170 |
|
$ |
239 |
|
$ |
830 |
Depreciation and amortization |
|
240 |
|
|
190 |
|
|
128 |
|
|
80 |
|
|
638 |
Restructuring and transaction activities (1) |
|
37 |
|
|
6 |
|
|
6 |
|
|
6 |
|
|
55 |
Other non-cash charges (2) |
|
29 |
|
|
9 |
|
|
4 |
|
|
6 |
|
|
48 |
Operating EBITDA |
$ |
501 |
|
$ |
431 |
|
$ |
308 |
|
$ |
331 |
|
$ |
1,571 |
|
|
|
|
|
|
|
|
|
|
|
Three Quarterly Periods Ended |
||||||||||||||
|
Consumer
|
|
Consumer
|
|
Health,
|
|
Engineered
|
|
Total |
||||||
Net sales |
$ |
153 |
|
|
$ |
1,892 |
|
$ |
1,904 |
|
$ |
1,910 |
|
$ |
5,859 |
|
|
|
|
|
|
|
|
|
|
||||||
Operating income |
$ |
(2 |
) |
|
$ |
168 |
|
$ |
160 |
|
$ |
250 |
|
$ |
576 |
Depreciation and amortization |
|
12 |
|
|
|
156 |
|
|
142 |
|
|
87 |
|
|
397 |
Restructuring and transaction activities (1) |
|
14 |
|
|
|
7 |
|
|
10 |
|
|
4 |
|
|
35 |
Other non-cash charges (2) |
|
— |
|
|
|
7 |
|
|
9 |
|
|
9 |
|
|
25 |
Operating EBITDA |
$ |
24 |
|
|
$ |
338 |
|
$ |
321 |
|
$ |
350 |
|
$ |
1,033 |
|
|
|
|
|
|
|
|
|
|
(1) |
Restructuring and transaction activity costs for the three quarterly periods ended |
|
(2) |
Other non-cash charges for the |
|
* Prior year has been restated to match our current structure. |
|
||||||||||||
Reconciliation Schedules |
||||||||||||
(Unaudited) |
||||||||||||
(in millions of dollars, except per share data) |
||||||||||||
|
Quarterly Period Ended |
|
Four Quarters
|
|
||||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
Net income |
$ |
191 |
|
|
$ |
13 |
|
|
$ |
596 |
|
|
Add: other expense, net |
|
(7 |
) |
|
|
136 |
|
|
|
2 |
|
|
Add: interest expense, net |
|
110 |
|
|
|
71 |
|
|
|
467 |
|
|
Add: income tax expense |
|
53 |
|
|
|
(5 |
) |
|
|
164 |
|
|
Operating income |
$ |
347 |
|
|
$ |
215 |
|
|
$ |
1,229 |
|
|
|
|
|
|
|
|
|
||||||
Add: non-cash amortization from 2006 private sale |
|
6 |
|
|
|
7 |
|
|
|
26 |
|
|
Add: restructuring and transaction activities (2) |
|
19 |
|
|
|
— |
|
|
|
(106 |
) |
|
Add: other non-cash charges (1) |
|
6 |
|
|
|
6 |
|
|
|
91 |
|
|
Adjusted operating income (6) |
$ |
378 |
|
|
$ |
228 |
|
|
$ |
1,240 |
|
|
|
|
|
|
|
|
|
||||||
Add: depreciation |
|
135 |
|
|
|
89 |
|
|
|
553 |
|
|
Add: amortization of intangibles (3) |
|
68 |
|
|
|
31 |
|
|
|
275 |
|
|
Operating EBITDA (6) |
$ |
581 |
|
|
$ |
348 |
|
|
$ |
2,068 |
|
|
|
|
|
|
|
|
|
||||||
Add: Pro forma adjustments (4) |
|
|
|
|
|
101 |
|
|
||||
Adjusted EBITDA (6) |
|
|
|
|
$ |
2,169 |
|
|
||||
Cash flow from operating activities |
$ |
446 |
|
|
$ |
240 |
|
|
$ |
1,609 |
|
|
Net additions to property, plant, and equipment |
|
(156 |
) |
|
|
(104 |
) |
|
|
(547 |
) |
|
Payment of tax receivable agreement |
|
— |
|
|
|
— |
|
|
|
(22 |
) |
|
Free cash flow (6) |
$ |
290 |
|
|
$ |
136 |
|
|
$ |
1,040 |
|
|
|
|
|
|
|
|
|
||||||
Net income per diluted share |
$ |
1.42 |
|
|
$ |
0.10 |
|
|
||||
Other expense, net |
|
(0.05 |
) |
|
|
1.01 |
|
|
||||
Non-cash amortization from 2006 private sale |
|
0.04 |
|
|
|
0.05 |
|
|
||||
Restructuring and transaction activities |
|
0.14 |
|
|
|
— |
|
|
||||
Income tax impact on items above (5) |
|
(0.03 |
) |
|
|
(0.26 |
) |
|
||||
Adjusted net income per diluted share (6) |
$ |
1.52 |
|
|
$ |
0.90 |
|
|
||||
|
|
|
|
|
||||||||
|
Estimated Fiscal
|
|
||||||||||
Cash flow from operating activities |
$ |
1,450 |
|
|
||||||||
Additions to property, plant, and equipment |
|
(620 |
) |
|
||||||||
Free cash flow (6) |
$ |
830 |
|
|
||||||||
|
|
|
(1) |
Other non-cash charges for the |
|
(2) |
The current quarter primarily includes transaction activity costs related to the RPC acquisition. The prior year quarter primarily includes transaction activities related to the |
|
(3) |
Amortization excludes non-cash amortization from the 2006 private sale of |
|
(4) |
Represents unrealized cost savings related to acquisitions partially offset by the Operating EBITDA from the SFL disposition under our ownership in the period. |
|
(5) |
Income tax effects on adjusted net income is calculated using 25 percent for both the |
|
(6) |
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in |
|
|
|
|
|
We define “free cash flow” as cash flow from operating activities less additions to property, plant, and equipment and payments under the tax receivable agreement. We believe free cash flow is useful to an investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We also believe free cash flow is useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash. |
|
|
|
|
|
Adjusted EBITDA is used by our lenders for debt covenant compliance purposes. We also use Adjusted EBITDA and Operating EBITDA among other measures to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA and Operating EBITDA and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s performance. We also believe EBITDA and Adjusted net income are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods. |
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20200731005075/en/
Company Contact:
+1 (812) 306 2964
ir@berryglobal.com
Source: